Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.57NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.49NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.9.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.69NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BZ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CK.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.36NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.5.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.41NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.75.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CR.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BT.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
BE.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XMNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.70NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.63NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.8.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EC.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XLNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BD.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.87 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used